PAHANG, MALAYSIA January 22, 2026 – Malaysian Prime Minister Datuk Seri Anwar Ibrahim concluded his working visit to Pahang with an on-site inspection of the Narcotics Addiction Rehabilitation Center (PUSPEN) Karak project, emphasizing the need for timely completion to benefit the public.
During the visit yesterday, Anwar was briefed on the project’s status, which had faced nearly 100 days of delays due to various issues. He noted that these challenges have been resolved, with construction now progressing smoothly and reaching approximately 92% completion.
Anwar, who also serves as Finance Minister, arrived at the site around 3 PM and spent time reviewing the remaining scope of work. He urged district officials, agencies, and contractors to address any outstanding problems promptly, highlighting that delays in multi-million ringgit projects deprive citizens of essential facilities and services.

The Prime Minister called for rigorous monitoring to ensure the center, designed to accommodate up to 500 residents, is fully operational by April 30, 2026. “Our goal is not just to complete the project, but to ensure that this rehabilitation process can help them rise again and return to building a more meaningful life,” Anwar stated in a post on X.
The PUSPEN Karak visit was part of a broader one-day itinerary in Pahang, which included a state development briefing at the Bentong District and Land Office, engagements with local communities, and discussions on education and social rehabilitation initiatives.
Photos from the event show Anwar and officials seated under a tented area, reviewing documents amid a backdrop of lush hills and the ongoing construction site. Media personnel and staff were present, capturing the proceedings.
This inspection underscores the government’s commitment to the Malaysia MADANI agenda, focusing on efficient project delivery and community welfare. The PUSPEN center aims to provide comprehensive rehabilitation for those affected by narcotics addiction, aligning with national efforts to combat drug-related issues.
